:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Neha Sharma, Rupa Mazumder, Pallavi Rai, Abhijit Debnath
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Chemical Biology & Drug Design
Accesso online:	https://onlinelibrary.wiley.com/doi/10.1111/cbdd.14613
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
di: Yihao Liu, et al.
Pubblicazione: (2026)

δ‐Tocotrienol Potentiates Breast and Prostate Cancer Cells to Paclitaxel via Suppressing PD‐L1‐Mediated Cancer‐Promoting Signaling
di: Zhenou Sun, et al.
Pubblicazione: (2025)

Substrate‐based synthetic strategies and biological activities of 1,3,4‐oxadiazole: A review
di: Upasana Sharma, et al.
Pubblicazione: (2024)

Emerging Roles of Osmium Complexes in Cancer Therapy, Their Mechanism of Action, Challenges and Future Perspectives
di: Eman M. Atiyah, et al.
Pubblicazione: (2026)

Reviewing the IDH1 Mutation‐Mediated Mechanism of Drug Resistance and Revisiting Its Overcoming Strategies
di: Yifan Wang, et al.
Pubblicazione: (2025)

Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4–LPS‐Mediated Migration in Triple‐Negative Breast Cancer Cells
di: S. K. Batin Rahaman, et al.
Pubblicazione: (2025)

Fused and Substituted Piperazines as Anticancer Agents: A Review
di: Saumya Singh, et al.
Pubblicazione: (2025)

Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
di: Vladislav Lobanov, et al.
Pubblicazione: (2025)

Investigation of the Inhibitory Effects and Underlying Mechanisms of Vitexin Derivatives Targeting CDK1 in HCT Colorectal Cancer Cells
di: Ying Zhao, et al.
Pubblicazione: (2026)

Mitotic Arrest Deficient 2 Like 1 Contributes to Colorectal Cancer Cell Migration, Invasion, and Oxaliplatin Resistance Through the Wnt/β‐Catenin Pathway
di: Xiang Ding, et al.
Pubblicazione: (2024)

Exploring Thiazole‐Based Heterocycles: Synthesis, Bioactivity, and Molecular Docking for Antimicrobial Applications
di: Hana M. Abumelha, et al.
Pubblicazione: (2025)

Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
di: Mohamed El Oirdi
Pubblicazione: (2024)

Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments
di: Wu Tao, et al.
Pubblicazione: (2024)

Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile
di: Ayse Mine Yilmaz, et al.
Pubblicazione: (2025)

Spalt‐Like Transcription Factor 4 Mediates Fatty Acid Oxidation to Foster 5‐Fluorouracil Resistance in Gastric Cancer Cells
di: Yong Zhu, et al.
Pubblicazione: (2025)

The medicinal chemistry of piperazines: A review
di: Md Faizan, et al.
Pubblicazione: (2024)

The Molecular Mechanism of Resveratrol in the Treatment of Chronic Rhinosinusitis Through a Combination of Network Pharmacology and In Vitro Validation
di: Xiao Cheng, et al.
Pubblicazione: (2025)

Correction to Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
Pubblicazione: (2024)

Molecular Mechanism of Dexmedetomidine in Alzheimer's Disease: Machine Learning Identifies RGS7 as a Key Therapeutic Targe
di: Yangliang Yang, et al.
Pubblicazione: (2025)

Advances in the Molecular Mechanism of Kappa Opioid Receptors Signaling and the Important Sampling Methods to Probe the Activation Landscape of GPCRs
di: Mingqiong Tong, et al.
Pubblicazione: (2025)

Exploring the Effect of Gomisin A on Non‐Small Cell Lung Cancer With Network Pharmacology, Molecular Docking, In Vitro and In Vivo Assays
di: Mei Liu, et al.
Pubblicazione: (2024)

Network Pharmacology, Machine Learning, Molecular Docking, and Cell Experiments Reveal the Therapeutic Mechanism of Radix Rehmanniae Praeparata in Psoriasis In Vitro
di: Tingting Zhang, et al.
Pubblicazione: (2026)

Platinum‐Based Chemotherapeutics in the Modern Era: From Classical DNA ‐Targeting Mechanisms to Next‐Generation Innovations in Cancer Therapy
di: Mohammad Bagher Shahsavani, et al.
Pubblicazione: (2025)

Curculigoside Induces Ferroptosis in Non‐Small Cell Lung Cancer Cells Through a Mechanism Involving Wilms' Tumor 1‐Associating Protein‐Mediated m6A Modification of GTP Cyclohydrolase 1
di: Lizheng Lv, et al.
Pubblicazione: (2026)

Network Pharmacology and Transcriptomic Analysis Reveal the Mechanism by Which Ginsenoside CK Remodels the Tumor Immune Microenvironment to Inhibit Liver Cancer Progression
di: Fangzhi Ye, et al.
Pubblicazione: (2025)

Multimodal Fusion of mpMRI Radiomics, Clinical Features, and Hematological Biomarkers Enhances Machine Learning‐Based Prediction of Biochemical Recurrence in Prostate Cancer Patients
di: Yinxing Zhu, et al.
Pubblicazione: (2025)

Investigating the Role of Quercetin, an Active Ingredient in Bazhen Decoction, in Targeting CXCL8 to Inhibit Macrophage M2 Polarization and Reshape the Immunological Microenvironment of Colorectal Cancer
di: Wenwu Wang, et al.
Pubblicazione: (2025)

In Vitro Cytotoxicity and Mechanistic Investigation of Quinazolin‐4(1H)‐One Linked Coumarin as a Potent Anticancer Agent
di: Dinesh Singla, et al.
Pubblicazione: (2024)

Skullcapflavone II Suppresses Colorectal Cancer by Inhibiting the HIF ‐1α‐Glycolysis Pathway
di: Shiwei Yang, et al.
Pubblicazione: (2025)

Anti‐metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes
di: Nur Sena Sivri, et al.
Pubblicazione: (2024)

Pyrazoline–Imidazopyridine Hybrids as Beclin‐1 Mimetics Driving Dual Apoptotic and Autophagy in Breast Cancer
di: Rashmi Shivakumar, et al.
Pubblicazione: (2026)

Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3/HIF‐1α Signaling
di: Lichao Ji, et al.
Pubblicazione: (2025)

Design, Hemisynthesis, Characterization, Molecular Docking, and Dynamics Evaluation of Novel Totarol‐1,2,3‐Triazole Derivatives as Leishmaniasis and Toxoplasmosis Agents
di: Ayoub Boualli, et al.
Pubblicazione: (2025)

Herbacetin Inhibits Human Fructose 1,6‐Bisphosphatase Among a Panel of Chromone Derivatives and Pyrazoles, Demonstrating Positive Effects on Insulin‐Resistant HepG2 Cells
di: Sónia Rocha, et al.
Pubblicazione: (2024)

Chemoresistance and Immune Suppression in Gastric Cancer Are Driven by PPDPF Overexpression
di: Chenqiang Pan, et al.
Pubblicazione: (2026)

Assessment of Antidiarrheal Activity of Fraxin in Chick: Synergistic Effects and Molecular Docking Study
di: Wahidul Alam, et al.
Pubblicazione: (2026)

Pachymic Acid Suppresses Endometrial Cancer Cell Migration by Inhibiting the NR3C1 / TGF ‐β/Smad Signaling Pathway
di: Yaqiong Wang, et al.
Pubblicazione: (2025)

Novel 10‐Alkoxy 1,4‐Dien‐3‐One Estranes as Multitarget Anticancer Agents Against Estrogen‐Positive Breast Cancer
di: Ivana Kuzminac, et al.
Pubblicazione: (2026)

Multi‐Omics and Machine Learning‐Driven Discovery of ABCC8 ( SUR1 ) for Diabetes Mellitus: Integrating Molecular Insights on Nigella sativa Bioactives and Sulfonylurea
di: Mohd Adnan, et al.
Pubblicazione: (2026)

Identification of Potential PBP2a Inhibitors Against Methicillin‐Resistant Staphylococcus aureus via Drug Repurposing and Combination Therapy
di: Fangfang Jiao, et al.
Pubblicazione: (2025)